
Stock Trend Analysis Report
Prepared for you on Saturday, September 23, 2023.
Navidea Biopharmaceuticals, Inc. (AMEX:NAVB)
Sidelines Mode (+55) - NAVB is moving in a sideways pattern and is unable to gain momentum in either direction. Beware of choppy movement and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid NAVB?
MarketClub looks at technical strength and momentum to determine if the timing is right for NAVB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for NAVB
The long-term trend has been DOWN since Apr 25th, 2023 at 0.221500
The intermediate-term trend has been UP since Aug 16th, 2023 at 0.108149
The short-term trend has been DOWN since Sep 18th, 2023 at 0.091000
Smart Scan Analysis for NAVB
Based on our trend formula, NAVB is rated as a +55 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
0.0923 | 0.0971 | 0.0917 | 0.0965 | +0.0016 |
Prev. Close | Volume | Bid | Ask | Time |
0.0964 | 3330900 | 2023-09-22 15:59:15 |
Year High | 0.4242 | Year High Date | 2018-03-09 |
Year Low | 0.125 | Year Low Date | 2018-08-16 |
52wk High | 0.35 | 52wk High Date | 2023-02-08 |
52wk Low | 0.0626 | 52wk Low Date | 2023-08-07 |
Year End Close | 2.83 | Average Volume | 6,534,239 |
Shares Outstanding | 99,831 | Short Interest | 18,176,460 |
% Institutional | 24.5 | Market Cap | 13M |
Assets | 8,219,812M | Liabilities | 9,298,913M |
P/E Ratio | -3.37500000 | Beta | 0.92 |
Volatility | 87.14 |